Session Information
AABB Audioconference Series 2012
Click here to go to the previous page
Improved Clinical Outcomes in HCT: A Donor and Patient Perspective
Track
:
Cellular Therapy
Program Code:
124690
Date:
Wednesday, January 11, 2012
Time:
2:00 PM to 3:30 PM
EST
DIRECTOR
:
Dr. John Miller, MD, PhD, Vice President and Senior Medical Director, Donor Medical Services
MODERATOR
:
Dr. John Miller, MD, PhD, Vice President and Senior Medical Director, Donor Medical Services
SPEAKER
(S):
Dr. John Miller, MD, PhD, Vice President and Senior Medical Director, Donor Medical Services
Navneet Majhail, MD, MS, Medical Director, Health Services Research, National Marrow Donor Program
Description
Developed in Conjunction with the National Marrow Donor Program
Since the first successful allogeneic hematopoietic cell (HC) transplants occurred using unrelated donors in the early 1970's, donor registries have grown to over 15 million HLA typed potential donors and over 12,000 unrelated donor transplants occur annually worldwide. This session will address the question of clinical outcomes of HCT. We continue to grow the number of donors on the NMDP registry and we are performing an ever increasing number of transplants for patients in need, but have we improved donor match rates and patient survival rates over the past several decades? This session will address the donor and patient related factors that impact clinical outcomes for the transplant patient and how donor registries and transplant physicians might continue to improve outcomes of transplantation in years to come.
*Cellular Therapy-focused Audioconference.
Since the first successful allogeneic hematopoietic cell (HC) transplants occurred using unrelated donors in the early 1970's, donor registries have grown to over 15 million HLA typed potential donors and over 12,000 unrelated donor transplants occur annually worldwide. This session will address the question of clinical outcomes of HCT. We continue to grow the number of donors on the NMDP registry and we are performing an ever increasing number of transplants for patients in need, but have we improved donor match rates and patient survival rates over the past several decades? This session will address the donor and patient related factors that impact clinical outcomes for the transplant patient and how donor registries and transplant physicians might continue to improve outcomes of transplantation in years to come.
*Cellular Therapy-focused Audioconference.
- Describe how survival after HCT has changed over time and what donor and patient factors may have led to these changes.
- Explain the current state of donor recruitment to the NMDP registry and how this has affected match rates for donors and their recipients.
- Review how more efficient systems and processes may affect transplant outcomes now and in the future.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |